Banner
Opioid Addicts Are Less Likely To Use Legal Opioids At The End Of Their Lives

With a porous southern border, street fentanyl continues to enter the United States and be purchased...

More Like Lizards: Claim That T. Rex Was As Smart As Monkeys Refuted

A year ago, corporate media promoted the provocative claim that dinosaurs like Tyrannorsaurus rex...

Study: Caloric Restriction In Humans And Aging

In mice, caloric restriction has been found to increase aging but obviously mice are not little...

Science Podcast Or Perish?

When we created the Science 2.0 movement, it quickly caught cultural fire. Blogging became the...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

Scientists in Japan have discovered a new species of bacteria, Microbacterium hatanonis, that can live in hairspray, according to the results of a study published in the March issue of the International Journal of Systematic and Evolutionary Microbiology.

“Contamination of cosmetic products is rare but some products may be unable to suppress the growth of certain bacteria,” says Dr Bakir from the Japan Collection of Microorganisms, Saitama, Japan. “We discovered a new species of bacteria called Microbacterium hatanonis, which we found contaminates hairspray.

Growing concern over increased levels of atmospheric carbon dioxide has prompted new interest in techniques for removing the gas from the smokestacks of such large-scale sources as coal-fired electric power plants. But to minimize their economic impact, the cost of adding such controls must be minimized so they don’t raise the price of electricity significantly.

Researchers have developed a new, low-cost material called hyperbranched aluminosilica for capturing carbon dioxide (CO2) from the smokestacks of coal-fired power plants and other generators of the greenhouse gas.

Transfer RNA is an ancient molecule, central to every task a cell performs and thus essential to all life. A new study from the University of Illinois indicates that it is also a great historian, preserving some of the earliest and most profound events of the evolutionary past in its structure.

Of the thousands of RNAs so far identified, transfer RNA (tRNA) is the most direct intermediary between genes and proteins. Like many other RNAs (ribonucleic acids), tRNA aids in translating genes into the chains of amino acids that make up proteins. With the help of a highly targeted enzyme, each tRNA molecule recognizes and latches onto a specific amino acid, which it carries into the protein-building machinery.

The discovery of the brain’s so-called melanocortin system and its central role in controlling appetite has paved the way for entirely new possibilities for treating obesity and anorexia. In the latest issue of the prestigious journal Nature Reviews Drug Discovery, Uppsala University researcher Jarl Wikberg and one of his associates present a review of pioneering research in this field that he and other scientists have conducted over nearly two decades.

The mapping of the melanocortin system was made possible by the cloning of genes for five different melanocortin receptors, which was performed by Jarl Wikberg in collaboration with other researchers in the early 1990s.

Ben Shneiderman of the University of Maryland, one of the world’s leading researchers and innovators in human-computer interaction, says it’s time for the laboratory research that has defined science for the last 400 years to make room for a revolutionary new method of scientific discovery.

He calls it Science 2.0. We couldn't agree more.

Yet he has apparently never read this website. He says Science 2.0 combines the hypothesis based inquiry of laboratory science with the methods of social science research to understand and improve the use of new human networks made possible by today’s digital connectivity. Through Science 2.0, the societal potential of such networks can be realized for applications ranging from homeland security to medical care to the environment.

Following last week’s study suggesting that new generation antidepressants aren’t all they’re cracked up to be, a special report in this week’s BMJ asks do we really know the truth about antidepressants? Or statins? Or any other drug on the market?

Lack of access to data is an ongoing problem in the United States, despite passage of the Food and Drug Administration Amendments Act (FDAAA) of 2007, which requires clinical trials to be registered in a public database, write Jeanne Lenzer and Shannon Brownlee.

Although it’s a positive step towards greater transparency, the act may not reduce the likelihood of dangerous or ineffective drugs remaining on the market as much as some people might have hoped, they warn. For example, not all trials have to be registered and access to full data is also constrained by trade secrecy laws.